The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Elimination of Colon Cancer Stem-Like Cells by the Combination of Curcumin and FOLFOX
Open accessAbstract
5-Fluorouracil (5-FU) or 5-FU plus oxaliplatin (FOLFOX) remains the backbone of colorectal cancer chemotherapeutics but with limited success. This could partly be due to the enrichment of cancer stem cells (CSCs) that are resistant to conventional chemotherapy. Therefore, validation of a nontoxic agent that can either cause reversal of chemoresistance or promote the killing of CSCs would be highly desirable. The current study examines whether curcumin, the major active ingredient of turmeric, either alone or together with FOLFOX, would be an effective strategy to eliminate colon CSCs. Exposure of colon cancer HCT-116 or HT-29 cells to FOLFOX that inhibited their growth led to the enrichment of CSC phenotype as evidenced by increased proportion of CD133-, CD44-, and/or CD166-positive cells and epidermal growth factor receptor (EGFR) levels. Treatment of FOLFOX-surviving colon cancer cells with either curcumin alone or together with FOLFOX resulted in a marked reduction in CSCs, as evidenced by the decreased expression of CD44 and CD166 as well as EGFR and by their ability to form anchorage-dependent colonies. They also caused disintegration of colonospheres. Increased expression of EGFR in FOLFOX-surviving cells could be attributed to hypomethylation of the EGFR promoter, whereas an opposite phenomenon was observed when the FOLFOX-surviving cells were treated with curcumin and/or FOLFOX. These changes were accompanied by parallel alterations in the levels of DNA methyltransferase 1. In conclusion, our data suggest that curcumin by itself or together with the conventional chemotherapeutic could be an effective treatment strategy for preventing the emergence of chemoresistant colon cancer cells by reducing/eliminating CSCs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
Effects of DNA methylation on DNA-binding proteins and gene expression
Tate, P. H., & Bird, A. P. (1993) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(93)90027-m · Cited by 737 · cited 1×
“Methylation of CpG sequences stabilizes chromatin, prevents binding of transcription factors, and is thought to be one of the primary mechanisms by which genes are turned on and off developmentally [25–27].”
Cited by
Curcumin, a component of turmeric: From farm to pharmacy
Gupta, S. C., Kismali, G., & Aggarwal, B. B. (2013) · BioFactors · doi:10.1002/biof.1079 · Cited by 396
Bao, B., Wang, Z., Ali, S., Ahmad, A., Azmi, A. S., Sarkar, S. H., Banerjee, S., Kong, D., Li, Y., Thakur, S., et al. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0299 · Cited by 337
Self-citationCurcumin: An age-old anti-inflammatory and anti-neoplastic agent
Fadus, M. C., Lau, C., Bikhchandani, J., & Lynch, H. T. (2017) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2016.08.002 · Cited by 318
Yu, Y., Kanwar, S. S., Patel, B. B., Oh, P.-S., Nautiyal, J., Sarkar, F. H., & Majumdar, A. P. N. (2012) · Carcinogenesis · doi:10.1093/carcin/bgr246 · Cited by 258
Self-citationGavrilas, L., Sava, O., Balacescu, L., Miron, S., Miere, D., Balacescu, O., & Cruceriu, D. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117386 · Cited by 2
Metadata
- Authors
- Yu, Y., Kanwar, S. S., Patel, B. B., Nautiyal, J., Sarkar, F. H., & Majumdar, A. P. N.
- Venue
- Translational Oncology
- Publisher
- Elsevier BV
- Published
- 2009-12
- Volume
- 2
- Issue
- 4
- Pages
- 321-328
- ISSN
- 1936-5233 (ISSN-L)
- OpenAlex
- W2020695289
- Cited by
- 223
- References
- 2
- FWCI
- 7.16
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Elimination of Colon Cancer Stem-Like Cells by the Combination of Curcumin and FOLFOX. https://app.cochat.ai/papers/10.1593/tlo.09193
- The paper
- Yu, Y., Kanwar, S. S., Patel, B. B., Nautiyal, J., Sarkar, F. H., & Majumdar, A. P. N. (2009). Elimination of Colon Cancer Stem-Like Cells by the Combination of Curcumin and FOLFOX. Translational Oncology. https://doi.org/10.1593/tlo.09193
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.